We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Invited Critique |

Nullius in Verba Comment on “Hepaticojejunostomy Using Short-Limb Roux-en-Y Reconstruction”

Brendan C. Visser, MD
JAMA Surg. 2013;148(3):257-258. doi:10.1001/jamasurg.2013.626.
Text Size: A A A
Published online


Much (perhaps most) of our day-to-day surgical practice is rooted in tradition and dogma. Hepatobiliary surgeons around the world routinely construct their Roux limb in preparation for a biliary anastomosis at anywhere between 40 cm and 70 cm to prevent reflux of enteric contents into the biliary tree and thus cholangitis. This practice makes basic sense and most everybody does it—thus, it is not often questioned.

Felder and colleagues1 challenge this basic tenet of hepatobiliary surgery. They describe a series of 70 patients over a decade that required Roux-en-Y hepaticojejunostomy for a breadth of indications. The authors' practice has been to minimize the distance between the ligament of Treitz and the enteroenterostomy and to create a short Roux limb of only 20 cm. With a respectable median follow-up of 49 months, their rate of complications was comparable with published series using the more standard Roux length. And, notably, their rate of cholangitis was very low. Certainly these data are vulnerable to critics of any retrospective case series. But the authors do not overanalyze or oversell it. And these data are as good or better than any of the sparse data supporting the tradition of a longer Roux.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles